CFO at Versigent (VGNT) granted 43,438 shares as stock award

Rhea-AI Filing Summary

Versigent PLC reported that its Chief Financial Officer, Douglas R. Ostermann, received a grant of 43,438 Ordinary Shares as a stock award. The shares were acquired at a reported price of $0.00 per share, indicating a compensation-related grant rather than a market purchase.

Following this award, the CFO directly holds 169,542 Ordinary Shares. This filing reflects an equity-based compensation event and does not show any open-market buying or selling activity.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ostermann Douglas R

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	43,438	$0.00	--

Holdings After Transaction: Ordinary Shares — 169,542 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 43,438 shares Post-transaction holdings: 169,542 shares Transaction price: $0.00 per share +1 more

4 metrics

Shares granted 43,438 shares Ordinary Shares grant on 2026-04-22

Post-transaction holdings 169,542 shares Direct Ordinary Shares held by CFO after grant

Transaction price $0.00 per share Reported price for granted Ordinary Shares

Acquisition type Grant/award acquisition Form 4 transaction code A for Ordinary Shares

Key Terms

Ordinary Shares, Grant, award, or other acquisition, Form 4, non-derivative

4 terms

Ordinary Shares financial

"security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

""transaction_type": "non-derivative""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ostermann Douglas R

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

SCHAFFHAUSEN SWITZERLAND 8200

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/22/2026		A		43,438	A	$0.00	169,542	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Janis Acosta, Attorney-in-fact for Douglas Ostermann	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Versigent (VGNT) disclose for its CFO?

Versigent disclosed that its CFO, Douglas R. Ostermann, received a grant of 43,438 Ordinary Shares. The shares were awarded at a stated price of $0.00 per share, reflecting equity compensation rather than an open-market purchase or sale.

How many Versigent (VGNT) shares does the CFO hold after this grant?

After the reported grant, the Versigent CFO directly holds 169,542 Ordinary Shares. This total includes the newly awarded 43,438 shares, as shown in the filing’s post-transaction ownership figure for non-derivative, directly held shares.

Was the Versigent (VGNT) CFO transaction a buy or a grant?

The transaction was a grant/award acquisition, coded as “A” on the Form 4. The filing labels it as a grant or award of shares, not an open-market purchase, with a reported transaction price of $0.00 per share for the Ordinary Shares.

Did the Versigent (VGNT) CFO sell any shares in this Form 4 filing?

No share sales are reported in this Form 4. The filing shows one acquisition transaction, a grant of 43,438 Ordinary Shares, and indicates no sell transactions in the summarized counts for buy, sell, acquire, and dispose activity.

Are there any Versigent (VGNT) derivative securities reported for the CFO?

The filing’s derivative section is empty, indicating no derivative transactions such as options or warrants in this report. The derivativeSummary field shows no remaining derivative positions, focusing solely on directly held Ordinary Shares.